Hostname: page-component-77c89778f8-9q27g Total loading time: 0 Render date: 2024-07-17T16:07:03.097Z Has data issue: false hasContentIssue false
  • English
  • Français

Hepatitis B Vaccine: Its Risks and Benefits

Published online by Cambridge University Press:  02 January 2015

Peter N.R. Heseltine
Peter N.R. Heseltine*
Affiliation:
Los Angeles County —, University of Southern California Medical Center, Los Angeles, California
*
Los Angeles County —, University of Southern California Medical Center, 1200 North State Street, Box 596, Los Angeles, CA 90033
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial Series: Hepatitis B Vaccine
Information
Infection Control & Hospital Epidemiology , Volume 3 , Issue 5 , October 1982 , pp. 373 - 374
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1982

References

1. Weiss, KE, Falvo, CE, Buimovici-Klein, E, et al: Evaluation of an employee health service as a setting for a rubella screening and immunization program. Am J Public Health 1979;69:281–283.CrossRefGoogle ScholarPubMed
2. Orenstein, WA, Heseltine, PNR, Le Gagnoux, SJ: Rubella vaccine and susceptible hospital employees. JAMA 1981;245:711–713.Google Scholar
3. Szmuness, W, Stevens, CE, Harley, EJ, et al: Hepatitis B vaccine: Demonstration of efficacy in a controlled clinical trial in a high risk population in the United States. N Engl J Med 1980;303:833–841.Google Scholar
4. Withers, JA: Hepatitis, review of the disease and significance to dentistry. J Periodontol 1980;51:162–166.Google Scholar
5. Szmuness, W: Hepatocellular carcinoma and the hepatitis B virus: Evidence for a causal association. Prog Med Virol 1978;24:40–49.Google ScholarPubMed